Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL

Adam S. Kittai, John N. Allan, Dan James, Helen Bridge, Miguel Miranda, Alan S. M. Yong, Fady Fam, Jack Roos, Vikram Shetty, Alan Skarbnik, Matthew S. Davids

Blood Adv (2024) 8 (11): 2861–2869.

https://doi.org/10.1182/bloodadvances.2023012142

Published: 2024

Includes: Supplemental data